Neuronetics Business Summary

Neuronetics, Inc. (STIM) is a vertically integrated medical technology leader specializing in non-invasive neurohealth therapies, primarily through its proprietary NeuroStar Advanced Therapy System. The company generates revenue through two core segments: the NeuroStar Business, which derives income from capital sales of Transcranial Magnetic Stimulation (TMS) systems and recurring per-treatment session fees, and the Clinic segment, which captures direct patient service revenue via its national network of Greenbrook TMS centers. This vertically integrated model, solidified by the late 2024 acquisition of Greenbrook, allows Neuronetics to control the entire value chain from device manufacturing to clinical delivery. Primary direct competitors include Brainsway Ltd. (BWAY), MagVenture, and eNeura, Inc. Neuronetics maintains a dominant market position as the largest TMS provider in the U.S., leveraging its extensive installed base and FDA clearances for major depressive disorder (MDD) and obsessive-compulsive disorder (OCD) to outpace hardware-focused peers. The company is led by President and CEO Keith J. Sullivan, a veteran with over 30 years of medical device experience who previously served as Chief Commercial Officer at ZELTIQ Aesthetics (acquired by Allergan). The executive team includes CFO Steven E. Pfanstiel, appointed in July 2025 with a deep background in life sciences from Myriad Genetics and Abbott Laboratories, and CTO Cory Anderson, who brings over 20 years of med-tech expertise from roles at Sebacia and The Innovation Factory. Neuronetics was originally founded in 2003 as a spin-out from The Innovation Factory incubator. Current governance is overseen by Chairman Rob Cascella, formerly of Philips Healthcare, with significant institutional backing from Madryn Asset Management, Vanguard, and BlackRock. This leadership group is currently focused on a strategic transition, as Sullivan is slated to retire in June 2026, while the firm optimizes its integrated clinic model to achieve sustained profitability.